期刊
JOURNAL OF NEUROSCIENCE RESEARCH
卷 91, 期 3, 页码 462-471出版社
WILEY
DOI: 10.1002/jnr.23160
关键词
3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride; DMXBA; neuroprotection; 6-hydroxydopamine; a7 nicotinic acetylcholine receptor; Parkinson's disease
资金
- Smoking Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology of Japan
- NIMH [061412]
- Grants-in-Aid for Scientific Research [23659384, 22390180, 25460109, 23659460] Funding Source: KAKEN
To explore a novel therapy against Parkinson's disease through enhancement of alpha 7 nicotinic acetylcholine receptor (nAChR), we evaluated the neuroprotective effects of 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (DMXBA; GTS-21), a functionally selective alpha 7 nAChR agonist, in a rat 6-hydroxydopamine (6-OHDA)-induced hemiparkinsonian model. Microinjection of 6-OHDA into the nigrostriatal pathway of rats destroys dopaminergic neurons selectively. DMXBA dose dependently inhibited methamphetamine-stimulated rotational behavior and dopaminergic neuronal loss induced by 6-OHDA. The protective effects were abolished by methyllycaconitine citrate salt hydrate, an alpha 7 nAChR antagonist. Immunohistochemical study confirmed abundant alpha 7 nAChR expression in the cytoplasm of dopaminergic neurons. These results indicate that DMXBA prevented 6-OHDA-induced dopaminergic neuronal loss through stimulating alpha 7 nAChR in dopaminergic neurons. Injection of 6-OHDA elevated immunoreactivities to glial markers such as ionized calcium binding adaptor molecule 1, CD68, and glial fibrillary acidic protein in the substantia nigra pars compacta of rats. In contrast, these immunoreactivities were markedly inhibited by comicroinjection of DMXBA. Microglia also expressed alpha 7 nAChR in both resting and activated states. Hence, we hypothesize that DMXBA simultaneously affects microglia and dopaminergic neurons and that both actions lead to dopaminergic neuroprotection. The findings that DMXBA attenuates 6-OHDA-induced dopaminergic neurodegeneration and glial activation in a rat model of Parkinson's disease raisethe possibility that DMXBA could be a novel therapeutic compound to prevent Parkinson's disease development. (c) 2012 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据